BroadOak Capital Partners
Bethesda, United States24
11M
20
1.33
6
0.17
3
- Areas of investment
Summary
BroadOak Capital Partners appeared to be the VC, which was created in 2006. The main office of represented VC is situated in the Bethesda. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the BroadOak Capital Partners, startups are often financed by Ben Franklin Technology Partners of Southeastern Pennsylvania, Z80 Labs Technology Incubator, Rand Capital. The meaningful sponsors for the fund in investment in the same round are Research Corporation Technologies, Oxford Finance LLC, Northpond Ventures. In the next rounds fund is usually obtained by Brooks Automation.
Among the most successful fund investment fields, there are Life Science, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Empire Genomics, Rubicon Genomics, Halo Labs.
The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 42 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 24
- Lead investments
- 6
- Exits
- 3
- Rounds per year
- 1.33
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (17)
- Health Care (6)
- Genetics (6)
- Life Science (6)
- Pharmaceutical (5) Show 17 more
- Investments by region
- United States (23)
- Israel (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 0.54
- Avg. company exit year
- 12
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AnalyzeLog | 25 Feb 2019 | Advertising, Digital Media | Seed | 0 | Chiyoda, Japan |
| Halo Labs | 20 Dec 2018 | Biotechnology, Analytics, Health Diagnostics, Pharmaceutical, Biopharma | Early Stage Venture | 5M | United States, Pennsylvania, Philadelphia |
| S2 Genomics | 23 Jan 2024 | Biotechnology, Health Care | Early Stage Venture | 16M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.